Spatial epi-proteomics enabled by histone post-translational modification analysis from low-abundance clinical...

Area of Science:

• Epigenetics and Molecular Biology
• Cancer Research
• Mass Spectrometry Applications

Background:

• Growing evidence links epigenetic mechanisms, particularly histone post-translational modifications (PTMs), to diseases like cancer.
• Previous methods for analyzing histone PTMs in clinical samples using mass spectrometry (MS) required substantial amounts of tissue.
• This limitation hindered the investigation of PTMs in small or heterogeneous clinical samples.

Purpose of the Study:

• To develop a streamlined protocol for analyzing histone PTMs from low-amount clinical samples.
• To enable MS-based analysis of histone PTMs from extremely small tissue areas (down to 1000 cells).
• To apply the developed method for spatial epi-proteomics in breast cancer tissues.

Main Methods:

• Streamlined protein extraction from low-input clinical samples.
• Optimization and implementation of in-gel digestion strategies for histone PTM analysis.
• Mass spectrometry (MS)-based quantification of histone PTMs from laser microdissected tissue areas.

Main Results:

• A novel protocol was established, enabling MS analysis of common histone PTMs from as few as 1000 cells.
• This represents a ~500-fold reduction in required sample material compared to existing methods.
• The protocol successfully identified differences in histone marks between heterogeneous regions in breast cancer tissues.

Conclusions:

• Analyzing histone PTMs from very small tissue areas and detecting regional differences is technically feasible.
• The developed method facilitates spatial epi-proteomics, integrating epigenetic analysis with tissue and tumor heterogeneity.
• This approach is crucial for identifying novel epigenetic biomarkers and understanding aberrant epigenetic mechanisms in diseases.